Advancing global disease research together
China Kadoorie Biobank (CKB) (ckbiobank.org) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Education brands, Other brands, in the 13th percentile of 12332 Healthcare brands.
The China Kadoorie Biobank (CKB) is a long-term UK-China research collaboration and one of the world's largest prospective cohort studies, encompassing data from over 512,000 adult participants. It generates evidence on lifestyle, environmental, and genetic determinants of common chronic diseases to inform disease prevention, risk prediction, and treatment strategies globally. CKB serves medical researchers, epidemiologists, and public health policymakers seeking large-scale epidemiological data.
| Brand Name | China Kadoorie Biobank (CKB) |
|---|---|
| Domain | ckbiobank.org |
| Industry | Healthcare, Education |
| Main Competitors | UK Biobank (78/100), All of Us Research Program, deCODE genetics (83/100), FinnGen (80/100), Million Veteran Program, BioBank Japan |
Moz Domain Authority 42/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "The China Kadoorie Biobank (CKB) is a long-term collaboration between the UK and China, to create one of the world’s largest prospective cohort studies" (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, Instagram, GitHub; no detected presence on X (Twitter), LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is China Kadoorie Biobank (CKB)?", Claude could identify the brand as of September 2026. China Kadoorie Biobank is a large-scale, long-term prospective study of over 512,000 adults across ten regions in China, set up to investigate how genetic, environmental, and lifestyle factors influence the development of chronic diseases like cancer, heart disease, and diabetes. Best known for Being one of the largest population-based cohort studies globally, used to research chronic disease risk factors in the Chinese population.
When asked "Best brands similar to China Kadoorie Biobank (CKB)?", Claude would recommend China Kadoorie Biobank (CKB) as of September 2026. If someone asked about major biobanks or epidemiological cohort studies, CKB would be a natural mention given its scale and influence on chronic disease research.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
China Kadoorie Biobank (CKB)'s main competitors in Healthcare: UK Biobank (78/100), deCODE genetics (83/100), FinnGen (80/100).
Sources: Brand Analyzer scan
China Kadoorie Biobank (CKB) is a long-term UK-China collaborative research initiative that has created one of the world's largest prospective cohort studies. It involves data from over 512,000 adult participants and is designed to investigate the lifestyle, environmental, and genetic determinants of common chronic diseases.
China Kadoorie Biobank (CKB) has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 45, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
China Kadoorie Biobank (CKB) scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
CKB is known for being one of the world's largest prospective cohort studies, resulting from a long-term UK-China research collaboration. It is recognized for its extensive participant base of over 512,000 adults and its contribution of large-scale epidemiological evidence on chronic disease determinants.
China Kadoorie Biobank (CKB) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
CKB's research and data are used by medical researchers, epidemiologists, public health policymakers, and academic institutions interested in chronic disease prevention, risk prediction, and the genetic and environmental determinants of health.
China Kadoorie Biobank (CKB) scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
China Kadoorie Biobank (CKB) has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (0/100). It benefits from a Moz Domain Authority of 42/100, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify China Kadoorie Biobank (CKB) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to China Kadoorie Biobank (CKB): Cityblock Health (66/100), Chemical Computing Group (CCG) (66/100), Clarity Technologies (66/100), Clear Lake (HCA Houston Healthcare) (66/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.